ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Cox Comm CL A SC23

Cox Comm CL A SC23 (COX)

0.00
0.00
(0.00%)
終了 12月2日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

COX 最新ニュース

Nicox first quarter 2015 financial and business update

SOPHIA ANTIPOLIS, France, April 17, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: FR0000074130, COX), the international ophthalmic company, today reported its first quarter 2015 revenues...

Nicox 2014 Financial Results and Business Update

A year of strategic progress: Positive phase 3 results for Vesneo(TM) (Bausch + Lomb); NDA submission on track for Q2 2015 Significant strengthening of ophthalmic therapeutics...

Nicox receives Orphan Drug Designation from FDA for naproxcinod in Duchenne Muscular Dystrophy

SOPHIA ANTIPOLIS, France, March 19, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: COX) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug...

Nicox signs exclusive license agreement with InSite Vision for AzaSite(R) and BromSite(TM) in Europe

InSite grants Nicox exclusive license for AzaSite® (1% azithromycin), BromSite(TM) (0.075% bromfenac) and AzaSite Xtra(TM) (2% azithromycin) in Europe, Middle East and...

Nicox holds successful pre-NDA meeting with FDA on AC-170 clinical package

SOPHIA ANTIPOLIS, France, Jan. 26, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced that it has held a positive pre-New Drug...

Nicox gains expanded North American rights for Sjo(TM) from Immco Diagnostics

Nicox gains expanded North American rights for Sjö(TM) from Immco Diagnostics Nicox acquires extension of rights to market Sjö(TM) to all healthcare practitioners in North...

Nicox focuses US operations on national launches of Sjo(TM) and RetnaGene(TM) and restructures RPS(R) licensing agreement

Nicox to focus US marketing resources on national roll-out of Sjö(TM) and launch of RetnaGene(TM) Rapid Pathogen Screening (RPS®) partnership for AdenoPlus® and two other...

Nicox to acquire Aciex Therapeutics, Inc.

Significant step forward in Nicox's strategy of creating an international ophthalmic company built around therapeutics and diagnostics Aciex brings a near-term pipeline of ophthalmic...

Nicox launches commercial operations in Germany

SOPHIA ANTIPOLIS, France, June 30, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced the launch of its German operations. Nicox...

Nicox and Sequenom announce the launch of expanded access to RetnaGene(TM) test portfolio in the U.S.

SOPHIA ANTIPOLIS, France and SAN DIEGO, June 19, 2014 (GLOBE NEWSWIRE) -- Nicox and Sequenom announce the launch of expanded access to RetnaGene(TM) test portfolio in the U.S. June 19...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
PERFPerfect Corp
US$ 2.61
(36.65%)
400.53k
SOSSOS Limited
US$ 12.40
(24.87%)
1.45M
ACHRArcher Aviation Inc
US$ 9.57
(18.44%)
60.5M
EVTLVertical Aerospace Ltd
US$ 10.10
(16.23%)
454.72k
NRDYNerdy Inc
US$ 1.58
(14.49%)
3.46M
ASAISendas Distribuidora SA
US$ 5.26
(-16.24%)
1.52M
AZULAzul SA
US$ 2.35
(-9.96%)
2.04M
CSANCosan SA
US$ 6.61
(-9.70%)
1.89M
SMRTSmartRent Inc
US$ 1.77
(-9.69%)
575.18k
ATIPATI Physical Therapy Inc
US$ 1.53
(-8.38%)
34.36k
BBDBanco Bradesco SA
US$ 2.13
(-5.75%)
62.17M
ACHRArcher Aviation Inc
US$ 9.57
(18.44%)
60.37M
NUNu Holdings Ltd
US$ 12.53
(-7.39%)
58.04M
QBTSD Wave Quantum Inc
US$ 3.02
(10.22%)
32.82M
VALEVale SA
US$ 9.86
(-0.10%)
28.74M

最近閲覧した銘柄

Delayed Upgrade Clock